Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Generic medicines news


From To
European Commission Must Stop Attacking Generic Medicines That Are The Lifeline Of Millions Around The World

ITPC calls on all parties at the negotiating table to preserve and protect India's ability to produce and export affordable generic drugs that are the only HIV treatment option for millions of women, men and children.

09 December 2010
Medical News Today
Generic erosion of key antiretroviral agents will limit growth in the HIV drug market to 2.2 percent a year from 2014 to 2019

Gilead's Quad will become the top-selling HIV agent, garnering major market sales of $2.8 billion in 2019, according to findings from Decision Resources.

27 October 2010
PR Newswire
Analysis: HIV generics under threat from tighter patenting rules

Most of the estimated 5.2 million people worldwide on antiretroviral (ARV) treatment are taking generic versions manufactured primarily in India, but tighter global intellectual property rights and trade rules could shut down "the pharmacy of the developing world".

02 August 2010
IRIN Plus News
← Prev12345Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.